I-Doxycycline hydrochloride CAS 10592-13-9
BUlwazi lwe-asic
| Igama lemveliso | I-Doxycycline hydrochloride |
| INOMBOLO YE-CAS. | 10592-13-9 |
| MF | C22H25ClN2O8 |
| MW | 480.9 |
| Indawo yokunyibilika | 195-201℃ |
| Inkangeleko | Umgubo wekristale otyheli okhanyayo |
Iinkcukacha ezongezelelwe
| Ukupakisha: | 25KG/Idrama, okanye njengemfuneko eyenzelwe wena |
| Imveliso: | Iitoni ezingama-500 ngonyaka |
| Uhlobo: | I-SENTON |
| Uthutho: | Ulwandle, Umoya, Umhlaba |
| Indawo Yokuqala: | iTshayina |
| Ikhowudi ye-HS: | 29413000 |
| Izibuko: | Shanghai, Qingdao, Tianjin |
Ingcaciso yeMveliso:
I-Doxycycline hydrochloride yipowder eluhlaza okwesibhakabhaka okanye etyheli ecwebezelayo, ayinavumba kwaye ikrakra, i-hygroscopic, inyibilika lula emanzini nakwi-methanol, inyibilika kancinci kwi-ethanol nakwi-acetone. Le mveliso ine-spectrum ebanzi ye-Antimicrobial kwaye isebenza kakuhle ngokuchasene ne-gram-positive cocci kunye ne-negative bacilli. Isiphumo se-antibacterial sinamandla aphindwe kalishumi kune-tetracycline, kwaye sisasebenza ngakumbi ngokuchasene neentsholongwane ezichasene ne-tetracycline. Isetyenziswa kakhulu kwizifo zomchamo, i-bronchitis engapheliyo, i-pneumonia, i-urinary system infection, njl. Ingasetyenziselwa ne-rash, i-typhoid, kunye ne-mycoplasma pneumonia.
Isicelo:
Isetyenziswa kakhulu kwizifo zosulelo lwendlela yokuphefumla ephezulu, iTonsillitis, usulelo lwendlela yenyongo, i-lymphadenitis, i-cellulitis, i-bronchitis engapheliyo yabantu abadala ebangelwa yintsholongwane ebuthathaka yegram kunye nentsholongwane engeyiyo igram, kwaye ikwasetyenziselwa unyango lweTyphus, isifo seempethu zeQiang, i-mycoplasma pneumonia, njl. Ingasetyenziselwa ukunyanga ikholera kunye nokuthintela imalariya enobungozi kunye nosulelo lwe-leptospira.
Ukulumkela
1. Iimpendulo zesisu zixhaphakile (malunga nama-20%), ezifana nokucaphuka, ukuhlanza, urhudo, njl. Ukusela amayeza emva kokutya kunokuziphelisa.
2. Ukusetyenziswa kufuneka kube kabini ngemini, njengokusebenzisa i-0.1g kanye ngemini, nto leyo enganelanga ukugcina uxinaniso olusebenzayo lweyeza egazini.
3. Kwizigulana ezinengxaki yesibindi nezintso encinci, ubomi obufutshane beli yeza abuhlukanga kangako kobo bukwizigulana eziqhelekileyo. Nangona kunjalo, kwizigulana ezinengxaki yesibindi nezintso enzima, kufuneka kuqatshelwe xa ulisebenzisa.
4. Ngokuqhelekileyo kufuneka ingavumelekanga kubantwana abangaphantsi kweminyaka esi-8 ubudala, abafazi abakhulelweyo, kunye nabasetyhini abancancisayo.













